Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human Phase 1 Trial

相似書籍

• Effect of the Anti‐C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody–Induced Complement Activation—A Preclinical In Vitro Study
  由: Wahrmann, M., et al.
  出版: (2017)
• Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003
  由: Valenzuela, Nicole M., et al.
  出版: (2017)
• Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients
  由: Mühlbacher, Jakob, et al.
  出版: (2020)
• Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
  由: Eskandary, Farsad, et al.
  出版: (2019)
• A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway
  由: Bartko, Johann, et al.
  出版: (2018)